Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Return on Equity (2016 - 2025)

Historic Return on Equity for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to 0.63%.

  • Champions Oncology's Return on Equity rose 40500.0% to 0.63% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.63%, marking a year-over-year increase of 40500.0%. This contributed to the annual value of 5.03% for FY2025, which is 103600.0% up from last year.
  • Latest data reveals that Champions Oncology reported Return on Equity of 0.63% as of Q4 2025, which was up 40500.0% from 0.8% recorded in Q3 2025.
  • Over the past 5 years, Champions Oncology's Return on Equity peaked at 9.9% during Q1 2024, and registered a low of 9.66% during Q4 2023.
  • For the 5-year period, Champions Oncology's Return on Equity averaged around 0.23%, with its median value being 0.05% (2021).
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -96700bps in 2023, then soared by 102900bps in 2024.
  • Over the past 5 years, Champions Oncology's Return on Equity (Quarter) stood at 0.05% in 2021, then tumbled by -76bps to 0.01% in 2022, then tumbled by -81262bps to 9.66% in 2023, then skyrocketed by 65bps to 3.43% in 2024, then surged by 118bps to 0.63% in 2025.
  • Its Return on Equity stands at 0.63% for Q4 2025, versus 0.8% for Q3 2025 and 1.02% for Q2 2025.